Anna Berglöf

1.8k total citations · 1 hit paper
29 papers, 1.3k citations indexed

About

Anna Berglöf is a scholar working on Immunology, Genetics and Molecular Biology. According to data from OpenAlex, Anna Berglöf has authored 29 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Immunology, 17 papers in Genetics and 8 papers in Molecular Biology. Recurrent topics in Anna Berglöf's work include Chronic Lymphocytic Leukemia Research (17 papers), Immunodeficiency and Autoimmune Disorders (13 papers) and T-cell and B-cell Immunology (6 papers). Anna Berglöf is often cited by papers focused on Chronic Lymphocytic Leukemia Research (17 papers), Immunodeficiency and Autoimmune Disorders (13 papers) and T-cell and B-cell Immunology (6 papers). Anna Berglöf collaborates with scholars based in Sweden, Colombia and United States. Anna Berglöf's co-authors include Smith Rjh, Leonardo Vargas, Abdalla Mohamed, Mauno Vihinen, Beston F. Nore, Liang Yu, H. Yesid Estupiñán, Rula Zain, K. Emelie M. Blomberg and Rani Faryal and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Blood.

In The Last Decade

Anna Berglöf

29 papers receiving 1.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Comparative Analysis of BTK Inhibitors and Mechanisms Underlying Adverse Effects

2021 166 citations H. Yesid Estupiñán, Anna Berglöf et al. Frontiers in Cell and Developmental Biology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Anna Berglöf Sweden	17	752	634	407	361	268	29	1.3k
Erica N Evans United States	19	288 0.4×	379 0.6×	487 1.2×	191 0.5×	232 0.9×	44	1.2k
Thomas Wossning Germany	10	447 0.6×	677 1.1×	334 0.8×	314 0.9×	131 0.5×	14	1.1k
Belinda Austen United Kingdom	13	568 0.8×	261 0.4×	412 1.0×	339 0.9×	85 0.3×	16	956
Jeffrey S. Painter United States	16	344 0.5×	635 1.0×	474 1.2×	211 0.6×	497 1.9×	28	1.3k
Sergio Roa United States	19	241 0.3×	601 0.9×	700 1.7×	322 0.9×	75 0.3×	35	1.3k
Charles Prussak United States	12	312 0.4×	378 0.6×	564 1.4×	144 0.4×	59 0.2×	35	1.0k
Nadja Zaborsky Austria	18	256 0.3×	386 0.6×	283 0.7×	138 0.4×	102 0.4×	49	945
Archito T. Tamayo United States	16	246 0.3×	413 0.7×	631 1.6×	393 1.1×	127 0.5×	34	1.2k
Sebastian Herzog Germany	21	214 0.3×	485 0.8×	713 1.8×	122 0.3×	296 1.1×	43	1.4k
Marcus Dühren-von Minden Germany	10	465 0.6×	410 0.6×	319 0.8×	332 0.9×	158 0.6×	11	886

Countries citing papers authored by Anna Berglöf

Since Specialization

Citations

This map shows the geographic impact of Anna Berglöf's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Berglöf with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Berglöf more than expected).

Fields of papers citing papers by Anna Berglöf

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anna Berglöf. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Berglöf. The network helps show where Anna Berglöf may publish in the future.

Co-authorship network of co-authors of Anna Berglöf

This figure shows the co-authorship network connecting the top 25 collaborators of Anna Berglöf. A scholar is included among the top collaborators of Anna Berglöf based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anna Berglöf. Anna Berglöf is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Estupiñán, H. Yesid, Thibault Bouderlique, Chenfei He, et al.. (2024). In BTK, phosphorylated Y223 in the SH3 domain mirrors catalytic activity, but does not influence biological function. Blood Advances. 8(8). 1981–1990. 3 indexed citations

Estupiñán, H. Yesid, Qing Wang, Anna Berglöf, et al.. (2021). BTK gatekeeper residue variation combined with cysteine 481 substitution causes super-resistance to irreversible inhibitors acalabrutinib, ibrutinib and zanubrutinib. Leukemia. 35(5). 1317–1329. 49 indexed citations

Estupiñán, H. Yesid, Anna Berglöf, Rula Zain, & Smith Rjh. (2021). Comparative Analysis of BTK Inhibitors and Mechanisms Underlying Adverse Effects. Frontiers in Cell and Developmental Biology. 9. 630942–630942. 166 indexed citations breakdown →

Estupiñán, H. Yesid, Thibault Bouderlique, Chenfei He, et al.. (2020). Novel mouse model resistant to irreversible BTK inhibitors: a tool identifying new therapeutic targets and side effects. Blood Advances. 4(11). 2439–2450. 18 indexed citations

Shi, Yuye, Mohammad H. Forouzanfar, Qing Wang, et al.. (2019). Combination of Gatekeeper Mutations and Cysteine 481 Replacement Causes Super Resistance to the Irreversible BTK Inhibitors Ibrutinib, Acalabrutinib and Zanubrutinib. Blood. 134(Supplement_1). 5759–5759. 3 indexed citations

Blomberg, K. Emelie M., Mohammad H. Forouzanfar, Liang Yu, et al.. (2016). Substitution scanning identifies a novel, catalytically active ibrutinib-resistant BTK cysteine 481 to threonine (C481T) variant. Leukemia. 31(1). 177–185. 47 indexed citations

Bestas, Burcu, Janne J. Turunen, K. Emelie M. Blomberg, et al.. (2015). Splice-Correction Strategies for Treatment of X-Linked Agammaglobulinemia. Current Allergy and Asthma Reports. 15(3). 510–510. 12 indexed citations

Berglöf, Anna, Janne J. Turunen, Olof Gissberg, et al.. (2013). Agammaglobulinemia: causative mutations and their implications for novel therapies. Expert Review of Clinical Immunology. 9(12). 1205–1221. 19 indexed citations

Blomberg, Karin, Nicole Boucheron, Jessica M. Lindvall, et al.. (2009). Transcriptional signatures of Itk-deficient CD3+, CD4+ and CD8+ T-cells. BMC Genomics. 10(1). 233–233. 18 indexed citations

10.

Mohamed, Abdalla, Liang Yu, Carl‐Magnus Bäckesjö, et al.. (2009). Bruton’s tyrosine kinase (Btk): function, regulation, and transformation with special emphasis on the PH domain. Immunological Reviews. 228(1). 58–73. 381 indexed citations

11.

Hasan, Maroof, Gabriela López‐Herrera, K. Emelie M. Blomberg, et al.. (2007). Defective Toll‐like receptor 9‐mediated cytokine production in B cells from Bruton's tyrosine kinase‐deficient mice. Immunology. 123(2). 239–249. 41 indexed citations

12.

Yu, Liang, Abdalla Mohamed, Leonardo Vargas, et al.. (2006). Regulation of Bruton Tyrosine Kinase by the Peptidylprolyl Isomerase Pin1. Journal of Biological Chemistry. 281(26). 18201–18207. 37 indexed citations

13.

Lindvall, Jessica M., K. Emelie M. Blomberg, Anna Berglöf, & Smith Rjh. (2006). Distinct gene expression signature in Btk-defective T1 B-cells. Biochemical and Biophysical Research Communications. 346(2). 461–469. 6 indexed citations

14.

Lindvall, Jessica M., K. Emelie M. Blomberg, Jouni Väliaho, et al.. (2005). Bruton's tyrosine kinase: cell biology, sequence conservation, mutation spectrum, siRNA modifications, and expression profiling. Immunological Reviews. 203(1). 200–215. 150 indexed citations

15.

Lindvall, Jessica M., Jouni Väliaho, K. Emelie M. Blomberg, et al.. (2005). Lindvall, J. M. et al. Bruton's tyrosine kinase: cell biology, sequence conservation, mutation spectrum, siRNA modifications, and expression profiling. Immunol. Rev. 203, 200-215. 43 indexed citations

16.

Lindvall, Jessica M., K. Emelie M. Blomberg, Anna Berglöf, et al.. (2004). Gene expression profile of B cells from Xid mice and Btk knockout mice. European Journal of Immunology. 34(7). 1981–1991. 23 indexed citations

17.

Vargas, Leonardo, Beston F. Nore, Anna Berglöf, et al.. (2002). Functional Interaction of Caveolin-1 with Bruton's Tyrosine Kinase and Bmx. Journal of Biological Chemistry. 277(11). 9351–9357. 50 indexed citations

18.

Berglöf, Anna, Tomas Norlander, Ricardo Feinstein, et al.. (2000). Association of Bronchopneumonia with Sinusitis Due to Bordetella Bronchiseptica in an Experimental Rabbit Model. American Journal of Rhinology. 14(2). 125–130. 4 indexed citations

19.

He, Bing, Mohammed A. Bakheit, Michael Levi, et al.. (1999). The role of B-cells in experimental myasthenia gravis in mice. Biomedicine & Pharmacotherapy. 53(5-6). 227–233. 3 indexed citations

20.

Berglöf, Anna, Karin Sandstedt, Ricardo Feinstein, Göran Bölske, & Smith Rjh. (1997). B cell‐deficient μMT mice as an experimental model for Mycoplasma infections in X‐linked agammaglobulinemia. European Journal of Immunology. 27(8). 2118–2121. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact